Everything below concerns visceral adiposity. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research supply is often accompanied by a certificate of analysis listing chromatographic purity, mass confirmation, and storage conditions. Laboratories compare that document with an independent test when material is intended for bench work, since certificates describe a batch rather than an individual vial. Published studies usually state the source and purity of the peptide because small differences in purity can shift measured activity. Full analytical validation is rarely reported, which leaves batch-to-batch comparability an open question.
The peptide is supplied as a lyophilized powder in single-use vials and is normally kept refrigerated between two and eight degrees Celsius, protected from light. Once dissolved, the solution is handled carefully because peptide bonds and the acyl modification can degrade under warm or alkaline conditions. Vials are inspected for cracks, and the powder is checked for color and uniformity before handling. Temperature excursions during shipping are a frequent reason for quality questions.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 2 to 8 °C | Refrigerated, protected from light |
| Appearance | White to off-white powder | Lyophilized cake in a single-use vial |
| Solubility | Soluble in water | Yields a clear solution after reconstitution |
| Identity method | Electrospray mass spectrometry | Confirms the expected molecular mass |
| Purity method | Reversed-phase HPLC | Reports main peak against related substances |
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
=== Pharmacokinetics === The conversion of codeine to morphine occurs in the liver and is catalyzed by the cytochrome P450 enzyme CYP2D6. CYP3A4 produces norcodeine, and UGT2B7 conjugates codeine, norcodeine, and morphine to the corresponding 3- and 6-glucuronides. Srinivasan, Wielbo, and Tebbett speculate that codeine-6-glucuronide is responsible for a large percentage of the analgesia of codeine, and thus these patients should experience some analgesia. CYP2D6 converts codeine into morphine, which then undergoes glucuronidation. Life-threatening intoxication, including respiratory depression requiring intubation, can develop over a matter of days in patients who have multiple functional alleles of CYP2D6, resulting in ultrarapid metabolism of opioids such as codeine into morphine. Studies on codeine's analgesic effect are consistent with the idea that metabolism by CYP2D6 to morphine is important, but some studies show no major differences between those who are poor metabolizers and extensive metabolizers. Evidence supporting the hypothesis that ultrarapid metabolizers may get greater analgesia from codeine due to increased morphine formation is limited to case reports. Due to the increased metabolism of codeine to morphine, ultrarapid metabolizers (those possessing more than two functional copies of the CYP2D6 allele) are at increased risk of adverse drug effects related to morphine toxicity.
Dimenoxadol (INN; also known as dimenoxadole (BAN) or dimenoxadole; brand name Estocin in Russia) is an opioid analgesic which is a benzilic acid derivative, closely related to benactyzine (an anticholinergic). Further, the structure is similar to methadone and related compounds like dextropropoxyphene. It was invented in Germany in the 1950s, and produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea. In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9617 and a 2013 annual aggregate manufacturing quota of zero.
=== Screening === Cardiovascular system screening is considered mandatory by the EASL, as MASLD outcomes often result in cardiovascular complications, which can manifest as subclinical atherosclerosis, the cause of most MASLD-related deaths. People with MASLD are at high risk for cardiovascular morbidity and mortality, and "aggressive modification of cardiovascular disease risk factors is warranted in all patients" according to AASLD. The AASLD further recommends that people with a cirrhotic MASH be systematically screened for gastric and esophageal varices and liver cancer. They do not recommend routine liver biopsies and screening for liver cancer for non-cirrhotic people with MASH, but such screening sometimes occurs on a case-by-case basis. Also, people with MASLD may be considered for screening for hepatocellular carcinoma (liver cancer) and gastroesophageal varices. The NICE advises regular screening of people with MASLD for advanced liver fibrosis every three years for adults and every two years for children using the enhanced liver fibrosis (ELF) blood test. Follow-up is recommended for people with obesity and insulin resistance using the homeostasis model assessment of insulin resistance (HOMA-IR). People with MASH with fibrosis and hypertension merit closer monitoring, as there is a higher risk of disease progression.
=== Chemical industry === J. Peter Grace became CEO and president of Grace in 1945. Under the new leadership, the company began diversifying from the established shipping industry and Latin American operations that it had created. The company went from 60% of sales volume for Latin American operations in the 1950s to 19% of sale volume in 1962. In 1954, the company bought Davison Chemical Company (founded by William T. Davison) and the Dewey & Almy Chemical Company (founded in 1919 by Bradley Dewey and Charles Almy). Chemical sales growth went from 6% of sales in 1950 to 55% in 1977. When J. Peter Grace in 1978 was asked what may have been the best decision by the company, he stated the following:Well, I'd say buying Dewey & Almy. We paid $37 million when it was earning about $1.8 million, at about 20 times earnings. Today, its earning about $60 million.
On 21 July 2011, following the exclusion of the original Salernitana club, Salerno mayor Vincenzo De Luca, in compliance with Article 52 of N.O.I.F., assigned the new title to Marco Mezzaroma, brother-in-law of Lazio owner and chairman Claudio Lotito. The new club was admitted to Serie D under the denomination of Salerno Calcio. In the 2011–12 season, Salernitana was immediately promoted to Lega Pro Seconda Divisione after winning Group G of Serie D. On 12 July 2012, the club was renamed US Salernitana 1919. In the 2012–13 Lega Pro Seconda Divisione season, Salernitana finished first in Girone B, and was promoted to Lega Pro Prima Divisione. This was the second consecutive promotion for the team. Finally Salernitana won Group C of Lega Pro and returned Serie B in 2014–15 season. After several seasons at Serie B level, Salernitana won promotion to Serie A at the end of the 2020–21 Serie B season under the tenure of head coach Fabrizio Castori, finishing in 2nd place behind champions Empoli. Promotion was secured with a 3–0 victory over Pescara on the final matchday. Salernitana's return to Serie A however required Lotito and Mezzaroma to sell the club, due to Italian football laws not allowing two clubs from the same owner to play in the same league. On 7 July 2021, the FIGC Federal Council approved the trust of Salernitana to take control of the club, meaning it was officially enrolled in Serie A for the first time in 23 years.
Sources: en.wikipedia.org
== Applications == Lithium, sodium, and potassium have many useful applications, while rubidium and caesium are very notable in academic contexts but do not have many applications yet. Lithium is the key ingredient for a range of lithium-based batteries, and lithium oxide can help process silica. Lithium stearate is a thickener and can be used to make lubricating greases; it is produced from lithium hydroxide, which is also used to absorb carbon dioxide in space capsules and submarines. Lithium chloride is used as a brazing alloy for aluminium parts. In medicine, some lithium salts are used as mood-stabilising pharmaceuticals. Metallic lithium is used in alloys with magnesium and aluminium to give very tough and light alloys. Sodium compounds have many applications, the most well-known being sodium chloride as table salt. Sodium salts of fatty acids are used as soap. Pure sodium metal also has many applications, including use in sodium-vapour lamps, which produce very efficient light compared to other types of lighting, and can help smooth the surface of other metals. Being a strong reducing agent, it is often used to reduce many other metals, such as titanium and zirconium, from their chlorides. Furthermore, it is very useful as a heat-exchange liquid in fast breeder nuclear reactors due to its low melting point, viscosity, and cross-section towards neutron absorption. Sodium-ion batteries may provide cheaper alternatives to their equivalent lithium-based cells.
The product must be thujone-free as per TTB guidelines, The word "absinthe" can neither be the brand name nor stand alone on the label, and The packaging cannot "project images of hallucinogenic, psychotropic, or mind-altering effects". Absinthe imported in violation of these regulations is subject to seizure at the discretion of U.S. Customs and Border Protection.
== Immune responses of the cornea == Innate immune responses defend against pathogens and toxins in a non-discriminatory manner. They provide an inherent barrier against corneal infection while also serving as a primary mode of defense that is present from birth. For instance, the orbit and the eyelid can guard against both traumatic events and exterior debris that may contain microorganisms. Other components of the ocular innate immune system include tears, epithelial cells, keratocytes, corneal nerves, the complement system, and interferons. Acquired immune responses are much more pathogen-specific than their innate immune counterparts. These pathways are cell-mediated and are understood to be controlled in part by Langerhans cells in the cornea. These Langerhans cells are antigen-presenting cells, which pick up pieces of invading pathogens and use them to elicit an immune response. Cell-mediated immune responses are much slower acting but more efficient, but can cause damage to surrounding tissue, resulting in damage to the vision.
LSD can rarely cause hallucinogen-induced psychotic disorder (HIPD), where after the drug has run its course, paranoia, delusions, hallucinations, or a reduced ability to communicate occur. A common presentation of hallucinogen-induced psychotic disorder is paranoia or severe anxiety days or weeks after LSD use. Hallucinogen-induced psychotic disorder is a medical emergency. It is also known under the more general term, substance-induced psychosis. The treatment for hallucinogen-induced psychotic disorder is atypical antipsychotics such as aripiprazole, quetiapine, or olanzapine, or risperidone. The condition occurs in fewer than 1% of people with psychedelics.
== Sustainability and environmental design == The University of Arizona generates renewable energy with solar panels (photo voltaic) that have been installed on campus buildings. In 2011, the Sustainable Endowments Institute gave the university a College Sustainability Report Card grade of "B." In 2015, the university opened the ENR2, housing the University of Arizona School of Geography, Development and Environment set to be one of its "greenest" buildings on campus with features like a cutting edge air conditioning system and 55,000-gallon water-harvesting tank. Designed to resemble a slot canyon in the Sonoran Desert, the 150,000 sq. ft. building focuses on adaptation and reducing our carbon footprint.
Sources: en.wikipedia.org
== External links == Clinical trial number NCT03354273 for "An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)" at ClinicalTrials.gov Clinical trial number NCT01347710 for "A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD" at ClinicalTrials.gov
Cancer research progress:The largest study of whole cancer genomes reports 58 new mutational signatures and shows that for each organ "cancers have a limited number of common signatures and a long tail of rare signatures". A study reports presence of certain bacteria in the prostate and urine for aggressive forms of prostate cancer, with biomarker- and therapeutic potentials being unclear (18 Apr). 25 April Novel foods such as under-development cultured meat, existing microbial foods and ground-up insects are shown to have the potential to reduce environmental impacts by over 80% in a study. A review about meat and sustainability of food systems, animal welfare, and healthy nutrition concludes that its consumption has to be reduced substantially for sustainable consumption and names broad potential measures such as "restrictions or fiscal mechanisms". A new type of cell death 'erebosis' is reported after copper-dependent cell death was first reported the previous month. 26 April Scientists report the detection of purine and pyrimidine nucleobases in several meteorites, including guanine, adenine, cytosine, uracil and thymine, and claim that such meteoritic nucleobases could serve as "building blocks of DNA and RNA on the early Earth".
Provides straightforward information about effects arising from individual compounds in complex or natural samples separated in parallel. Combines chromatographic separation with effect-directed detection using enzymatic or biological assays. Helps to select important compounds from a sample for further characterization using high-resolution mass spectrometry. Offers unique benefits such as super-hyphenation, minimum sample preparation requirements, detection of multi-modulating compounds, and distinguishing agonistic versus antagonistic effects.
Radiation protection measures may also be necessary against scattered radiation, which occurs during tumor irradiation of the head and neck on metal parts of the dentition (dental fillings, bridges, etc.). Since the 1990s, soft tissue retractors known as radiation protection splints have been used to prevent or reduce mucositis, an inflammation of the mucous membranes. It is the most significant adverse acute side effect of radiation. The radiation protection splint is a spacer that keeps the mucosa away from the teeth and reduces the amount of scattered radiation that hits the mucosa according to the square law of distance. Mucositis, which is extremely painful, is one of the most significant detriments to a patient's quality of life and often limits radiation therapy, thereby reducing the chances of tumor cure. The splint reduces oral mucosal reactions that typically occur in the second and third third of a radiation series and are irreversible.
Peptidoglycan, murein or mucopeptide is a unique large macromolecule, a polysaccharide, consisting of sugars and amino acids that forms a mesh-like layer (sacculus) that surrounds the bacterial cytoplasmic membrane. The sugar component consists of alternating residues of β-(1,4) linked N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM). Attached to the N-acetylmuramic acid is an oligopeptide chain made of three to five amino acids. The peptide chain can be cross-linked to the peptide chain of another strand forming the 3D mesh-like layer. Peptidoglycan serves a structural role in the bacterial cell wall, giving structural strength, as well as counteracting the osmotic pressure of the cytoplasm. This repetitive linking results in a dense peptidoglycan layer which is critical for maintaining cell form and withstanding high osmotic pressures, and it is regularly replaced by peptidoglycan production. Peptidoglycan hydrolysis and synthesis are two processes that must occur in order for cells to grow and multiply, a technique carried out in three stages: clipping of current material, insertion of new material, and re-crosslinking of existing material to new material. The peptidoglycan layer is substantially thicker in gram-positive bacteria (20 to 80 nanometers) than in gram-negative bacteria (7 to 8 nanometers). Depending on pH growth conditions, the peptidoglycan forms around 40 to 90% of the cell wall's dry weight of gram-positive bacteria but only around 10% of gram-negative strains.
Sources: en.wikipedia.org
Lyophilized material is typically kept refrigerated and away from light in the sealed vial provided. Dissolved material is generally used within a limited period rather than stored long term.
Mass spectrometry gives the molecular weight, and mapping after digestion gives sequence coverage. Reversed-phase chromatography then supplies a purity profile.
Different groups report purity with different methods and thresholds, and full validation data are seldom published. Direct comparison of activity across batches therefore stays uncertain.
It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.